Pharma Journalist - Page 880 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Sorrento Announces Completion of GMP Manufacturing Plant in Suzhou

Alcami Corporation to invest $5 million to expand Charleston County operations

Dragonfly Therapeutics appointed Dr. Asya Grinberg as Head of Biologics

Vivet Therapeutics recieves €37.5 million in a Series A financing for advancement in metabolic diseases treatment

BioPharmX achieves primary endpoint in its phase 2b Clinical Trial evaluating BPX-011

CARsgen announces the opening of CAR-T cell manufacturing facility in Shanghai

Cannabics Pharmaceutical collaborates with CTC European lab

Sobi Appoints Guido Oelkers as New President and CEO

Concordian International appoints Tzhak Krinsky and Francis Perier, Jr. as members of Board of Directors

David Price appointed as Chief Financial Officer Concordia International